Lawsuit > Personal Injury Lawsuits > Mirapex
PRODUCTS LIABILITY GUIDE: Products Liability Law,
Asbestos & Mesothelioma,
Benzene,
Food Poisoning,
Lead Poisoning,
Manganese,
Silicosis,
SJS - Stevens Johnson Syndrome,
Teflon,
Toxic Birth Defects,
Toxic Mold,
Vinyl Chloride,
Guidant,
Medtronic,
Ortho Evra,
Antidepressants,
Paxil,
Prozac,
Remeron,
ADHD Drugs,
Adderall,
Accutane,
Trasylol,
Amiodarone,
Avandia,
Bextra,
Chantix,
Cox-2 Inhibitors,
Fen-Phen - PPH,
Fosamax,
Ketek,
Mirapex,
Tamiflu,
Thimerosal,
Vioxx,
Vytorin,
Zetia,
Zocor,
ZyprexaTalk to Products Liability Lawyers & Attorneys in:
Albany,
Albuquerque,
Ann Arbor,
Appleton,
Arlington,
Atlanta,
Austin,
Baltimore,
Baton Rouge,
Birmingham,
Bismarck,
Boston,
Brooklyn,
Bronx,
Buffalo,
Charleston (SC),
Charleston (WV),
Charlotte,
Chicago,
Cincinnati,
Cleveland,
Colorado Springs,
Columbia,
Columbus,
Dallas,
Dayton,
Denver,
Des Moines,
Detroit,
El Paso,
Fargo,
Fort Lauderdale,
Fort Wayne,
Fort Worth,
Fresno,
Grand Rapids,
Green Bay,
Greenville,
Greensboro,
Hartford,
Honolulu,
Houston,
Indianapolis,
Jacksonville,
Kansas City,
Las Vegas,
Lehigh Valley,
Little Rock,
Long Island,
Los Angeles,
Louisville,
Madison,
Main Line,
Manhattan,
Memphis,
Miami,
Milwaukee,
Minneapolis,
Montgomery,
Montgomery County,
Nashville,
New Haven,
New Orleans,
New Jersey - Central,
New Jersey - Northern,
New Jersey - Southern,
New York City,
Northern Virginia,
Oakland,
Oklahoma City,
Omaha,
Orange County,
Orlando,
Philadelphia,
Phoenix,
Pittsburgh,
Portland,
Providence,
Queens,
Raleigh,
Richmond,
Rochester,
Rockford,
Sacramento,
Salt Lake City,
San Antonio,
San Diego,
San Francisco,
San Jose,
Savannah,
Seattle,
Springfield (IL),
Springfield (MO),
St. Louis,
Staten Island,
Syracuse,
Tampa,
Toledo,
Tucson,
Tulsa,
Victoria,
Virginia Beach,
Washington DC,
Westchester
If you don't see your location above,
click here for additional locations
Product Liability Attorneys
MIRAPEX
Mirapex, also known as pramipexole, has recently been linked to compulsive gambling addictions. The drug is generally prescribed to treat the symptoms of Parkinson's and other movement disorders.
Mirapex is a dopamine agonist. This means it stimulates nerves in the brain which are normally stimulated by dopamine, a brain chemical that helps control motor functions and movement. Mirapex is the most commonly prescribed drug in its class.
Mirapex Patients Falling Asleep During Activities of Daily Living
Patients treated with MIRAPEX have reported falling asleep while engaged in activities of daily living, including the operation of motor vehicles which sometimes resulted in accidents. Although many of these patients reported somnolence while on MIRAPEX, some perceived that they had no warning signs such as excessive drowsiness, and believed that they were alert immediately prior to the event. Some of these events have been reported as late as one year after the initiation of treatment.
Somnolence is a common occurrence in patients receiving MIRAPEX at doses above 1.5 mg/day. Many clinical experts believe that falling asleep while engaged in activities of daily living always occurs in a setting of pre-existing somnolence, although patients may not give such a history. For this reason, prescribers should continually reassess patients for drowsiness or sleepiness, especially since some of the events occur well after the start of treatment. Prescribers should also be aware that patients may not acknowledge drowsiness or sleepiness until directly questioned about drowsiness or sleepiness during specific activities.
Before initiating treatment with MIRAPEX, patients should be advised of the potential to develop drowsiness and specifically asked about factors that may increase the risk with MIRAPEX such as concomitant sedating medications, the presence of sleep disorders, and concomitant medications that increase MIRAPEX plasma levels (e.g., cimetidine –see PRECAUTIONS, Drug Interactions). If a patient develops significant daytime sleepiness or falling asleep during activities that require active participation (e.g., conversations, eating, etc.), MIRAPEX should ordinarily be discontinued. If a decision is made to continue MIRAPEX, patients should be advised to not drive and to avoid other potentially dangerous activities. While dose reduction clearly reduces the degree of somnolence, there is insufficient information to establish that dose reduction will eliminate episodes of falling asleep while engaged in activities of daily living.
